Pay-As-You-Go Effects for S. 3525, as Introduced on September 12, 2012
Cost Estimates Search
- Cost Estimate
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187,the Food and Drug Administration Safety and Innovation Act, with Further Amendments Adopted by the Senate through May 24, 2012
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187, the Food and Drug Administration Safety and Innovation Act
- Cost Estimate
Estimate of direct spending and revenues effects for the bill as cleared by the Congress on December 9, 2006, and signed by the President on December 22, 2006
- Cost Estimate
Estimate of direct spending and revenues effects for the bill as cleared by the Congress on September 30, 2006, and signed by the President on October 13, 2006
- Cost Estimate
Estimate of direct spending and revenues effects for the bill as cleared by the Congress on September 30, 2006, and signed by the President on October 16, 2006
- Cost Estimate
Estimate of direct spending and revenues effects for the bill as cleared by the Congress on September 12, 2006, and signed by the President on September 27, 2006
- Cost Estimate
Cost estimate for the bill as passed by the Senate on May 25, 2006
- Cost Estimate
Cost estimate for the bill as cleared by the Congress on July 31, 2006
- Cost Estimate
Estimate of direct spending and revenues effects for the bill as passed by the House of Representatives on July 29, 2006.